September 14, 2016

Chest pain accounts for approximately 8-10 million healthcare visits in the U.S. per year and can be associated with a variety of benign to life-threatening diseases. Acute coronary syndrome is one of the major considerations in the ED. Approximately 20% of lawsuits are due to misdiagnosis and mismanagement of ACS and a large percentage of patients are admitted due to this risk. However, few admitted patients go on to be diagnosed with ACS. Although commonly used to help risk stratify patients in the ED, there is no evidence that stress testing decreases risk of future cardiac events. This post will examine chest pain risk stratification in the ED and the utility of stress testing.